ARTICLE | Clinical News
Skeletal Targeted Radiotherapy (STR): Phase III trials update
March 26, 2001 8:00 AM UTC
NeoRx Corp. (NERX), Seattle, Wash. Product: Skeletal Targeted Radiotherapy (STR) Business: Cancer Therapeutic category: Cytotoxic Target: Bone cells Description: Radiolabeled DOTMP bone-targeting smal...